Messages in brief

News

CHMP Meeting Highlights June 2021

messages in brief | 07/07/2021
Up-to-date information from the June 21-24 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights June 2021 Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/06/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

CHMP Meeting Highlights May 2021

messages in brief | 17/06/2021
Up-to-date information from the May 17-20 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights May 2021 Read more
News

Comirnaty (COVID-19-mRNA-Vaccine)

messages in brief | 02/06/2021
On May 28, 2021, the use "for active immunization of individuals 12 years of age and older" was extended by the EMA.
Comirnaty (COVID-19-mRNA-Vaccine) Read more
News

Innovation in the eService Marketing Authorisation and Lifecycle

messages in brief | 25/05/2021
As of 22.5.2021, the function "Withdrawal according to §23 AMG" will be available in the area "Overview Medicinal Products".
Innovation in the eService Marketing Authorisation and Lifecycle Read more
News

EU Recommendations for the Seasonal Influenza Vaccine Composition for the Season 2021/2022

messages in brief | 10/05/2021
The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2021/2022 (published 30 March 2021)
EU Recommendations for the Seasonal Influenza Vaccine Composition for the Season 2021/2022 Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/04/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

New recommendation for dosing interval of mRNA-COVID-19 vaccines

messages in brief | 26/03/2021
National Vaccination Committee recommends extended dosage intervals for mRNA vaccines
New recommendation for dosing interval of mRNA-COVID-19 vaccines Read more
News

Release of the temporarily put on hold vaccine batch

messages in brief | 19/03/2021
The Austrian Federal Office for Safety in Health Care (BASG) informs that the temporarily put on hold batch ABV 5300 of AstraZeneca's COVID 19 vaccine has been released again and can be vaccinated.
Release of the temporarily put on hold vaccine batch Read more
News

Incidents after vaccination with AstraZeneca's COVID-19 vaccine

messages in brief | 07/03/2021
Currently, there is no evidence of a causal relationship with vaccination.
Incidents after vaccination with AstraZeneca's COVID-19 vaccine Read more
Email

Further inquiry note